A Phase I/II Clinical Trial of LBL-033 in the Treatment of Advanced Malignant Tumors
Status:
Not yet recruiting
Trial end date:
2026-03-31
Target enrollment:
Participant gender:
Summary
This trial is an open and multicenter phase I/II clinical study, which aims to evaluate the
safety, tolerability, PK characteristics, immunogenicity, and effectiveness.